A heated debate is erupting across social media as fitness influencer James Smith doubles down on his support for GLP-1 medications like Retatrutide—despite built his entire brand around calorie deficits.
Many personal trainers and health coaches are furious, accusing him of contradicting his core message.
But Smith insists nothing has changed about his beliefs—only the tools available to help people who desperately need them.
In a recent video addressing the controversy, the self-proclaimed “calorie deficit guy” explains why he believes these medications represent a breakthrough for severely obese individuals who’ve exhausted every other option.
Jump to:
- The Calorie Deficit Principle Hasn’t Changed
- The Red Zone: Where Traditional Methods Fail
- Why GLP-1 Medications Change Everything
- Personal Trainers Should Be Celebrating, Not Complaining
- The Three Pillars of Health Working Synergistically
- Addressing the “Abuse” Concern
- The Broader Societal Impact
- The Bottom Line
The Calorie Deficit Principle Hasn’t Changed
Smith emphasizes that his fundamental position remains rock solid: weight loss requires a calorie deficit, period.
Whether someone achieves that through intermittent fasting, low-carb diets, or reducing insulin—all roads lead back to eating fewer calories than the body burns.
The fitness industry for a long time has kept the principle out of arms reach. People don’t want to know about energy balance so they can sell them fat loss with their desired method.
His mission has always been empowering people to understand this basic truth rather than buying into expensive programs that obscure the underlying science.
Smith advocates finding a calorie target through experimentation—adjusting by 5-10% until discovering a sustainable number that produces results without constant misery.
The Red Zone: Where Traditional Methods Fail
After thousands of hours training clients, Smith identifies what he calls “the red zone”—individuals with BMIs over 30 who are severely obese.
These are people weighing 150 kilograms or more, struggling to climb stairs, limited to only a handful of exercises.
Almost every single client I’ve had in the red zone, for decades, I have failed. You know when you start training them that you can’t help them. It’s a pretty deflating thing for a coach and a trainer to have.
He stresses these individuals aren’t lazy—they’ve tried everything before seeking professional help.
Their challenges extend far beyond what a personal trainer’s scope of practice can address. Personal trainers can’t provide therapy, can’t explore childhood trauma, and in many jurisdictions can’t even create detailed meal plans.
Why GLP-1 Medications Change Everything
Smith’s enthusiasm stems from a simple fact: GLP-1 medications suddenly make the calorie deficit accessible to people who couldn’t achieve it before.
By suppressing appetite, these drugs provide the missing link for individuals whose eating behaviors couldn’t be modified through willpower alone.
Where I could only help this amount of people before, I can now help a wider amount because the calorie deficit here can now be accessed by anyone.
Critics argue there aren’t sufficient long-term studies on newer GLP-1 variants like Retatrutide. Smith counters that existing medications have 10-20 years of evidence, and severely obese individuals face immediate life-threatening risks.
Cardiovascular disease, stroke, diabetes, and dramatically diminished quality of life represent clear and present dangers.
The Risk-Benefit Calculation
For someone staring down these conditions, potential medication side effects pale in comparison to the certainty of continued severe obesity.
If GLP-1s help transition them out of the danger zone, the probability of living longer with better quality dramatically increases.
Personal Trainers Should Be Celebrating, Not Complaining
Smith finds the fitness industry backlash baffling because trainers’ core job responsibilities haven’t changed one bit.
Whether someone arrives slightly overweight or after using GLP-1 medication, personal trainers still need to focus on two critical areas:
- Preventing muscle loss: Designing resistance training programs that preserve lean tissue during weight loss
- Ensuring adequate nutrition: Monitoring protein intake, overall calories, fiber, and micronutrient consumption
Stories of people developing poor bone density or “fading away” on GLP-1s result from neglecting these fundamentals—not the medications themselves.
I don’t understand why personal trainers have got their knickers in such a twist because if someone comes to you at a normal slightly overweight BMI, we get them to train weights. If someone’s coming to you after using a GLP-1, you do the same thing.
An Expanding Market Opportunity
Rather than threatening personal trainers’ livelihoods, Smith predicts GLP-1s will dramatically expand the fitness industry over the next 5-10 years.
Global obesity rates are already declining. Millions of people who never felt welcome in gyms will soon have the physical capacity and confidence to start training.
Trainers will have an entirely fresh population eager to learn squats, deadlifts, and proper programming—people who can finally engage with fitness after years of physical limitations.
The Three Pillars of Health Working Synergistically
Smith outlines three interconnected health pillars for overweight individuals:
- Fitness: Cardiovascular conditioning, VO2 max improvement, regular movement
- Fat: Reducing excess body fat that contributes to disease risk
- Food: Improving diet quality with whole foods, adequate protein, sufficient fiber
Improving any single pillar enhances health—even if the others remain unchanged. Cardiovascular fitness strongly correlates with longevity regardless of body composition.
But here’s the critical insight: changing diet quality is extraordinarily difficult, often requiring 6-12 months of gradual modifications.
For the first time in history, people with excessive amounts of body fat in a matter of weeks and months, doctors can prescribe people a drug that reduces their appetite to the point that we can reduce the amount of fat that they have.
The Positive Cascade Effect
When severely obese individuals lose significant weight, they naturally become more inclined to exercise. Their improved appearance and physical capability create tremendous motivation.
This newfound fitness and confidence then drives interest in eating better—creating a virtuous cycle across all three pillars.
However, without first addressing excess fat, many people never reach the other two pillars. Their appetite and physical limitations create insurmountable barriers to both fitness and dietary improvement.
Addressing the “Abuse” Concern
Critics worry about people lying to doctors or editing photos to obtain GLP-1 prescriptions when they don’t truly need them.
Smith’s response? That’s between patients and their healthcare providers.
If someone misrepresents their condition to obtain any medication—whether for weight loss, pain management, or other purposes—that’s a matter of medical ethics and personal responsibility, not a reason to deny access to people who genuinely need help.
The Broader Societal Impact
Smith envisions profound positive effects as GLP-1 medications become more affordable and widely available:
- More people pursuing fitness and healthy lifestyles
- Increased dating and family formation
- Greater economic productivity
- Reduced healthcare costs and disability benefits
- Improved mental health and overall life satisfaction
Less losers, more happy people, more people dating, more people having families, more people contributing to the economy, less people on benefits.
He acknowledges the irony that someone who built a business helping people lose weight without medication is now advocating for pharmaceutical intervention.
If anyone should oppose GLP-1s from a business perspective, it would be him. Yet he views their development as unequivocally positive—even if it potentially reduces demand for his services.
The Bottom Line
Smith maintains his core identity as “the calorie deficit guy” remains intact. Weight loss still requires consuming fewer calories than the body expends.
GLP-1 medications simply provide a new method for achieving that principle—one that works for people who couldn’t succeed with willpower-based approaches alone.
As medications like Retatrutide receive regulatory approval and become more accessible, Smith predicts they’ll only improve in safety and efficacy.
Personal trainers and fitness professionals who view this as threatening their livelihoods are missing the bigger picture: an explosion of new clients who finally have the physical capacity to benefit from their expertise.
I just can’t fathom why so many people are so bitterly disappointed with these medications. If you don’t like that, we can agree to disagree. These drugs are only going to get better.
For individuals trapped in severe obesity with failed attempts at every traditional intervention, GLP-1 medications may represent the difference between continued deterioration and genuine transformation—finally making health and fitness accessible to those who need it most.
